ESE3/EHF, a promising target of rosiglitazone, suppresses pancreatic cancer stemness by downregulating CXCR4.

Autor:	Tianxing Zhou, Jing Liu, Yongjie Xie, Shuai Yuan, Yu Guo, Weiwei Bai, Kaili Zhao, Wenna Jiang, Hongwei Wang, Haotian Wang, Tiansuo Zhao, Chongbiao Huang, Song Gao, Xiuchao Wang, Shengyu Yang, Jihui Hao
Předmět:	PANCREATIC tumors PANCREATIC cancer CXCR4 receptors AGAR ROSIGLITAZONE CADHERINS STEM cell niches MACROPHAGE colony-stimulating factor
Zdroj:	Gut; Feb2022, Vol. 71 Issue 2, p357-371, 63p
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu